BIO
Bio-Rad Laboratories Inc
387.50$
+2.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 39.2% | 39.8% | 41.1% | 41.4% | 41.3% | 43.6% | 42.9% | 43.7% | 44.0% | 45.3% | 44.1% | 45.8% | 45.4% | 44.0% | 43.4% | 43.2% | 43.9% | 44.7% | 45.8% | 44.5% | 45.0% | 45.0% | 46.5% | 45.6% | 43.5% | 43.9% | 44.1% | 46.6% | 46.3% | 48.0% | |
| 60.8% | 60.2% | 58.9% | 58.6% | 58.7% | 56.4% | 57.1% | 56.3% | 56.0% | 54.7% | 55.9% | 54.2% | 54.6% | 56.0% | 56.6% | 56.8% | 56.1% | 55.3% | 54.2% | 55.5% | 55.0% | 55.0% | 53.5% | 54.4% | 56.5% | 56.1% | 55.9% | 53.4% | 53.7% | 52.0% | |
| 9.5% | 10.8% | 9.4% | 9.3% | 9.4% | 9.4% | 9.3% | 9.4% | 9.9% | 9.7% | 9.7% | 9.6% | 9.0% | 9.2% | 8.9% | 9.0% | 10.3% | 9.9% | 10.1% | 9.6% | 10.0% | 11.6% | 8.7% | 8.8% | 8.6% | 8.9% | 9.2% | 9.3% | 11.5% | 9.9% | |
| 37.1% | 38.6% | 37.8% | 35.4% | 34.1% | 33.3% | 32.4% | 32.4% | 34.7% | 35.2% | 34.5% | 34.8% | 33.5% | 33.7% | 33.0% | 33.6% | 33.0% | 37.4% | 37.2% | 37.7% | 39.5% | 37.4% | 36.5% | 35.7% | 31.4% | 30.1% | 29.5% | 31.7% | 31.7% | 32.7% | |
| 50.9% | 54.0% | 51.9% | 49.7% | 49.5% | 42.7% | 41.7% | 41.8% | 44.6% | 45.0% | 44.1% | 44.4% | 45.8% | 42.9% | 41.9% | 42.6% | 43.3% | 47.3% | 47.3% | 47.3% | 49.4% | 49.0% | 45.1% | 44.4% | 39.9% | 38.9% | 38.7% | 40.8% | 43.2% | 41.7% | |
| 10.0% | 6.2% | 7.0% | 8.8% | 9.2% | 13.7% | 15.4% | 14.5% | 10.0% | 9.8% | 11.5% | 9.3% | 10.4% | 12.9% | 14.7% | 14.2% | 12.8% | 7.9% | 6.9% | 8.3% | 2.6% | 5.4% | -4.7% | 9.9% | 16.6% | 17.1% | 17.2% | 12.6% | 10.5% | 10.5% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.5% | 2.2% | 1.8% | 2.6% | 3.3% | 2.6% | 2.5% | 2.9% | 1.0% | 1.1% | 1.1% | 1.1% | 1.0% | 1.0% | 0.9% | 0.1% | 1.4% | 1.9% | 1.9% | 1.9% | |
| 8.7% | 5.3% | 7.7% | 3.0% | 6.3% | 7.9% | 11.7% | 11.3% | 8.9% | 7.9% | 11.1% | 8.3% | 8.1% | 10.4% | 11.4% | 11.4% | 11.2% | 5.3% | 6.0% | 7.2% | 2.0% | 4.5% | 22.2% | 97.8% | 193.2% | 186.4% | -167.9% | -31.8% | -91.3% | 38.5% | |
| 2.2% | 1.5% | 2.2% | 0.9% | 1.9% | 2.5% | 4.1% | 3.7% | 2.8% | 1.3% | 3.0% | 1.8% | 2.5% | 2.1% | 1.7% | 2.8% | 3.0% | 1.6% | 2.0% | 1.6% | 0.6% | -0.8% | 6.4% | 21.7% | 43.4% | 40.9% | -38.4% | -8.0% | -19.4% | 9.1% | |
| 6.3% | 3.8% | 5.5% | 2.1% | 4.3% | 5.4% | 7.6% | 7.6% | 6.3% | 6.9% | 8.1% | 6.4% | 5.1% | 8.1% | 9.6% | 8.6% | 8.2% | 3.6% | 4.1% | 5.6% | 1.4% | 5.3% | 15.8% | 76.1% | 149.8% | 145.6% | -129.5% | -23.9% | -71.9% | 29.4% | |
| 13.6% | 10.8% | 11.8% | 13.8% | 15.2% | 18.8% | 20.2% | 18.9% | 15.9% | 14.9% | 18.0% | 15.0% | 15.4% | 18.8% | 20.4% | 19.8% | 19.5% | 14.3% | 14.0% | 14.8% | 10.0% | 12.5% | 29.5% | 106.4% | 199.5% | 191.2% | -160.2% | -24.5% | -83.5% | 48.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.